Literature DB >> 19184997

Dopaminergic modulation of brain systems subserving decision making under uncertainty: a study with fMRI and methylphenidate challenge.

R G M Schlösser1, I Nenadic, G Wagner, S Zysset, K Koch, H Sauer.   

Abstract

There is evidence that the dopaminergic system is involved in probabilistic reinforcement learning and reward-related decision-making. However, little is known about the effects of external dopaminergic challenges on processing of uncertainty in decision-making tasks. Therefore, the present study examined changes in fMRI activation patterns in a natural sampling paradigm. Decision making under uncertainty was examined before and after administration of a single dose of 40 mg methylphenidate as an acute dopaminergic pharmacological challenge. We found that the level of uncertainty was positively correlated with activations in the prefrontal cortex. Conversely, negative correlations with uncertainty were found in the left hippocampus, right amygdale, and right middle temporal gyrus. The drug intervention with methylphenidate revealed a differential picture. Uncertain information processing was associated with higher activation in the parietal association cortex and posterior cingulate cortex after placebo relative to methylphenidate. The methylphenidate challenge relative to placebo was associated with higher left and right parahippocampal as well as cerebellar activation under uncertainty. Apparently, the pro-dopaminergic pharmacological influence induces a relative shift towards recruitment of hippocampal areas under uncertainty, whereas under placebo conditions, higher levels of parietal cortex activations are involved in the task. The findings suggest a role of dopamine in uncertainty processing and shed light on the pharmacological mechanisms of methylphenidate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184997     DOI: 10.1002/syn.20621

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  22 in total

1.  Reinforcing efficacy of fat, as assessed by progressive ratio responding, depends upon availability not amount consumed.

Authors:  F H E Wojnicki; R K Babbs; R L W Corwin
Journal:  Physiol Behav       Date:  2010-03-16

2.  The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task.

Authors:  Peter Manza; Sien Hu; Jaime S Ide; Olivia M Farr; Sheng Zhang; Hoi-Chung Leung; Chiang-shan R Li
Journal:  J Psychopharmacol       Date:  2016-01-11       Impact factor: 4.153

3.  Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.

Authors:  Kathrin Finke; Chris M Dodds; Peter Bublak; Ralf Regenthal; Frank Baumann; Tom Manly; Ulrich Müller
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

Review 4.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

5.  From uncertainty to reward: BOLD characteristics differentiate signaling pathways.

Authors:  Birgit Abler; Bärbel Herrnberger; Georg Grön; Manfred Spitzer
Journal:  BMC Neurosci       Date:  2009-12-22       Impact factor: 3.288

Review 6.  Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors:  M Elizabeth Smith; Martha J Farah
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

Review 7.  The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans.

Authors:  Robert D Rogers
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

Review 8.  Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.

Authors:  Marisa E Marraccini; Lisa L Weyandt; Joseph S Rossi; Bergljot Gyda Gudmundsdottir
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

9.  Distributed effects of methylphenidate on the network structure of the resting brain: a connectomic pattern classification analysis.

Authors:  Chandra Sekhar Sripada; Daniel Kessler; Robert Welsh; Michael Angstadt; Israel Liberzon; K Luan Phan; Clayton Scott
Journal:  Neuroimage       Date:  2013-05-16       Impact factor: 6.556

10.  Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls.

Authors:  D Tomasi; N D Volkow; G J Wang; R Wang; F Telang; E C Caparelli; C Wong; M Jayne; J S Fowler
Journal:  Neuroimage       Date:  2010-10-26       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.